Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
Ontology highlight
ABSTRACT: This purpose of this study is to investigate whether the number and size of rectal polyps can be reduced in patients with Familial Adenomatous Polyposis (FAP) by using a highly-purified form of a naturally occurring substance, the omega-3 fatty acid, eicosapentaenoic acid (EPA).
DISEASE(S): Fap,Adenomatous Polyposis Coli,Colorectal Neoplasms,Familial Adenomatous Polyposis Coli,Nasopharyngeal Neoplasms
PROVIDER: 2042795 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA